E-LIB Suche - Ergebnisse für: Kroeger, N.

1

Prognostic factors for cellular therapies ‐ CART and alloge..:

Glass, B. ; Sureda, A. ; Boumendil, A....
Hematological Oncology. 41 (2023) S2 - p. 449-451 , 2023

Link: https://doi.org/10.1002/..

2

P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THER..:

Derigs, P. ; Bethge, W. ; Holtick, U....
HemaSphere. 6 (2022) - p. 1331-1332 , 2022

Link: https://doi.org/10.1097/..

3

Improving the definition of high-risk patients for tumor re..:

Lebacle, C. ; Kroeger, N. ; Pooli, A....
European Urology Supplements. 18 (2019) 1 - p. e84-e85 , 2019

Link: https://doi.org/10.1016/..

4

The UCLA histo-genetic risk classification (U-HGRC) to stra..:

Lebacle, C. ; Pooli, A. ; Rao, N....
European Urology Supplements. 18 (2019) 1 - p. e92-e93 , 2019

Link: https://doi.org/10.1016/..

5

Rare and changeable as a chameleon: paraneoplastic syndrome..:

Hegemann, M. ; Kroeger, N. ; Stenzl, A..
World Journal of Urology. 36 (2018) 6 - p. 849-854 , 2018

Link: https://doi.org/10.1007/..

6

Significance of Molecular and Cytogenetic TP53 Status in MD..:

Ganster, C. ; Schaab, R. ; Shirneshan, K....
Leukemia Research. 55 (2017) - p. S108-S109 , 2017

Link: https://doi.org/10.1016/..

7

Alloreactivity: the Janus-face of hematopoietic stem cell t..:

for the European Society for Blood and Marrow Transplantation (EBMT) ; Gratwohl, A ; Sureda, A...
Leukemia. 31 (2017) 8 - p. 1752-1759 , 2017

Link: https://doi.org/10.1038/..

8

Validation of BRCA1 associated protein-1 (BAP-1) as an adve..:

Skibbe, M. ; Guenther, K. ; Kapur, P....
European Urology Supplements. 16 (2017) 3 - p. e1717-e1718 , 2017

Link: https://doi.org/10.1016/..

9

Receptor activator of NFκB (RANK)-mediated induction of met..:

Steven, A. ; Kroeger, N. ; Leisz, S....
European Urology Supplements. 16 (2017) 3 - p. e1721-e1722 , 2017

Link: https://doi.org/10.1016/..

10

Schmerztherapie akuter Nierenkoliken: Nichtsteroidale Antir..:

Schmidt, S. ; Kroeger, N.
Der Urologe. 55 (2016) 3 - p. 386-390 , 2016

Link: https://doi.org/10.1007/..

11

Immuntherapie beim fortgeschrittenen Nierenzellkarzinom:

Schmidt, S. ; Kunath, F. ; Kroeger, N.
Der Urologe. 54 (2015) 5 - p. 716-720 , 2015

Link: https://doi.org/10.1007/..

12

Registry based retrospective analysis of bendamustine condi..:

Floro, L. ; Benjamin, R. ; van Biezen, A....
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. e164 , 2015

Link: https://doi.org/10.1016/..

13

1107 Outcomes of patients with non clear cell renal cell ca..:

Kroeger, N. ; Xie, W. ; Lee, J-L....
European Urology Supplements. 12 (2013) 1 - p. e1107-e1108 , 2013

Link: https://doi.org/10.1016/..

14

193 High cytoplasmic and low nuclear expression of HIF-2α a..:

Kroeger, N. ; Seligson, D.B. ; Signoretti, S....
European Urology Supplements. 12 (2013) 1 - p. e193-e194 , 2013

Link: https://doi.org/10.1016/..

15

Transforming growth factor β in prostate cancer; "Transform..:

Stope, M.B. ; Rönnau, C. ; Schubert, T....
Der Urologe. 52 (2012) 3 - p. 378-383 , 2012

Link: https://doi.org/10.1007/..